A Member of the University of Maryland Medical System | In Partnership with the University of Maryland School of Medicine
Malignant melanoma - choroid; Malignant melanoma - eye; Eye tumor; Ocular melanoma
Small melanomas may be treated with lasers, brachytherapy, or radiation therapy.
Surgical removal of the eye (enucleation) may be necessary.
Chemotherapy or biological therapy (interferon) are considered less effective therapies for melanoma involving the eye.
For additional resources, see cancer support group.
The outcome for melanoma of the eye depends on the size of the cancer at the time of diagnosis. Most patients will survive at least 5 years from the time of diagnosis if the cancer has not spread outside the eye.
If the cancer has spread outside the eye, the chance of survival is much lower.
Call for an appointment with your health care provider if you have symptoms of melanoma of the eye.
In: Abeloff MD, Armitage JO, Niederhuber JE, Kastan MB, McKena WG, eds. Clinical Oncology. 4th ed. Philadelphia, Pa: Elsevier Churchill Livingstone; 2008:chap 73.
A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).
© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.800.492.5538